why choose us

🌐 Go to WebHealthNetwork.com
Go to Consumers Chat
First received: March 20, 2025

Clinical Trial: A Study of TAK-881 and HyQvia in Healthy Adults

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Healthy Volunteers

Study Type: INTERVENTIONAL


Official Title: A Phase 1, Randomized, Open-Label, Pharmacokinetic Trial of TAK-881 and HyQvia in Healthy Adults

Brief Summary: The main aim of this study is to understand how the body absorbs, processes, and removes (known as pharmacokinetics or PK) TAK-881 and HyQvia, after they are given as a single injection under the skin in healthy adults.Study participants will receive a single dose of TAK-881 or HyQvia on Day 1.During the study, participants will need to stay at the clinic for 8 days followed by 8 ambulatory follow up visits till Day 85.

Read more